4AB:FRA
AbbVie Common Stock
262,80 €
arrow_upward
+1,04%(+2,70) 1D
20 қар., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
259,20 €
High
262,80 €
Low
258,60 €
Mkt. cap
505,89 млрд
Avg. vol.
101,00
Volume
75,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 мың
Open
259,20 €
High
262,80 €
Low
258,60 €
Mkt. cap
505,89 млрд
Avg. vol.
101,00
Volume
75,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 мың
News stories
From web sources and news partners
Yahoo Finance
·
1 сағат бұрын
$500,000 in AbbVie and Gilead Could Pay More Than $11,000 a Year in Dividends
Yahoo Finance
·
6 сағат бұрын
AbbVie (ABBV) Stock Just Got a 5.2% Dividend Increase. Here's How Many Shares You Need to Generate $1,000 a Year.
ad-hoc-news.de
·
10 сағат бұрын
AbbVie stock: Piper Sandler raises target to USD 349
Yahoo Finance
·
19 сағат бұрын
Is Solid Tumor Partnership Altering The Investment Case For AbbVie (ABBV)?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websiteabbvie.com